BioNTech SE vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
4.6
Underperform
Overall
6.5
Hold
Quality
Health
Growth
Valuation
Sentiment
BNTX
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ currently unprofitable (-40% margin).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $130.91 (+25.5%)
18 analysts
HOLD
Target $29.00 (+8.4%)
27 analysts
Fundamentals
BNTX
PFE
—
Trailing P/E
19.7×
-23.4×
Forward P/E
9.5×
-39.6%
Profit Margin
12.4%
78.7%
Gross Margin
75.8%
-5.9%
ROE
8.9%
-23.7%
Revenue Growth
-1.2%
—
Earnings Growth
—
1.59
Beta
0.39
—
Price / Book
—
$26.4B
Market Cap
$152.2B
$80 – $124
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.